Abstract:ObjectivesTo evaluate the ability of iodine uptake parameters from hepatic multiphasic CT to predict liver fibrosis, and compare absolute contrast enhancement (ΔHU) with dual-energy iodine density (ID) methods.MethodsOne hundred seventeen patients with pathologically proven liver fibrosis who underwent dual-energy CT during portal-venous phase (PVP) and 3-min delayed phase (DP) between January 2017 and Octotber 2019 were retrospectively included. Two radiologists measured the hepatic and blood-pool iodine uptake using ΔHU and ID methods; extracellular volume fraction (ECV) and the iodine washout rate (IWR) calculated with both methods were compared between different fibrosis stages (F0–1 vs. F2–4, F0–2 vs. F3–4, or F0–3 vs. F4). The inter-observer reproducibility (intraclass correlation coefficients [ICCs]) for ECV and IWR was compared between the ΔHU and ID methods. The areas under the receiver operating characteristic curves (AUCs) to predict liver fibrosis severity were calculated for serum and imaging fibrosis markers. To identify independent predictors, multivariable logistic regression analysis was performed, and combined performance was assessed for the ΔHU and ID models.ResultsPatients with F ≥ 2 (n = 70), F ≥ 3 (n = 51), and F4 (n = 29) had higher ECV and lower IWR than those with F ≤ 1, F ≤ 2, and F ≤ 3, respectively (all p < 0.001). ICCs were higher in the ID method than in the ΔHU method (ECV: p = 0.045; IWR: p < 0.001). The AUC ranges of ECVΔHU, ECVID, IWRΔHU, and IWRID for predicting liver fibrosis severity were 0.65–0.71, 0.67–0.73, 0.76–0.81, and 0.81–0.85, respectively. IWR and fibrosis-4 index were independent predictors, with combined AUCs of 0.82–0.87 for the ΔHU model and 0.86–0.89 for the ID model.ConclusionsIWR more accurately predicted liver fibrosis than ECV in routine multiphasic CT. The dual-energy ID method yielded higher inter-observer reproducibility and predictive values than the single-energy ΔHU method.Key Points• The IWR calculated from hepatic iodine uptake during PVP and 3-min DP predicted liver fibrosis (AUC, 0.76–0.85), while the ECV had a relatively limited predictive value (ACU, 0.65–0.73).• Compared with the conventional ΔHU method, the dual-energy ID method provided superior inter-observer reproducibility for measurement of ECV (p = 0.046) and IWR (p < 0.001).• The IWR and FIB-4 served as independent predictors of liver fibrosis; their combination yielded the high diagnostic performance particularly when using the ID method (combined AUCs of 0.86–0.89).

Usefulness of iodine-blood material density images in estimating degree of liver fibrosis by calculating extracellular volume fraction obtained from routine dual-energy liver CT protocol equilibrium phase data: preliminary experience

Comparison of Liver Fibrosis and Function Indices with Extracellular Volume Using Dual-energy CT: A Retrospective Study

Noninvasive assessment of liver fibrosis by dual-layer spectral detector CT

Iodine Density Changes in Hepatic and Splenic Parenchyma in Liver Cirrhosis with Dual Energy CT (DECT): A Preliminary Study.

Liver fibrosis assessment with multiphasic dual-energy CT: diagnostic performance of iodine uptake parameters

Extracellular volume by dual-energy CT, hepatic reserve capacity scoring, CT volumetry, and transient elastography for estimating liver fibrosis

Extracellular volume fraction obtained by dual-energy CT depicting the etiological differences of liver fibrosis

The clinical value of dual-energy CT-based iodine quantification parameters in the evaluation of hemodynamics and liver function in patients with cirrhosis

Iodine material density images in dual-energy CT: quantification of contrast uptake and washout in HCC

Iodine Images in Dual-energy CT: Detection of Hepatic Steatosis by Quantitative Iodine Concentration Values

The clinical value of hepatic extracellular volume fraction using routine multiphasic contrast-enhanced liver CT for staging liver fibrosis

Stratification of Patients With Liver Fibrosis Using Dual-Energy CT

Comparison between CT volumetry and extracellular volume fraction using liver dynamic CT for the predictive ability of liver fibrosis in patients with hepatocellular carcinoma

Efficacy Analysis of Double-Low Dynamic Contrast-Enhanced CT and Hepatic Extracellular Volume Fraction in the Diagnosis of Liver Fibrosis

Assessing Liver Fibrosis in Chronic Hepatitis B Using MR Extracellular Volume Measurements: Comparison with Serum Fibrosis Indices

Hepatic Fibrosis: Evaluation with Semiquantitative Contrast-enhanced CT

Synthetic extracellular volume fraction without hematocrit sampling for hepatic applications

[Study on Diagnostic Value of Extracellular Volume Imaging by Magnetic Resonance Imaging for Liver Fibrosis of Hepatitis B].

Quantitative Study of Hemodynamics of Spleen on Cirrhosis Patients by Dual-energy CT

[Investigation on Diagnosing Hepatic Fibrosis with X-ray Diffraction-Enhanced Imaging].

Spectral Ct: Preliminary Studies In The Liver Cirrhosis